All stock lists
Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
Healthcare · Biotechnology
2.39+0.03 (+1.27%)
Insider Score
––Not scored
BOLD Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
BOLD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 284.00 K | 307.00 K | 310.00 K | 317.00 K | 0.00 |
| Gross Profit | 0.00 | -284.00 K | -307.00 K | -310.00 K | -317.00 K | 0.00 |
| SG&A Expense | 10.41 M | 4.74 M | 4.19 M | 4.47 M | 4.84 M | 5.20 M |
| R&D Expense | 13.97 M | 9.73 M | 10.44 M | 10.36 M | 11.90 M | 12.14 M |
| Operating Expenses | 24.38 M | 14.19 M | 13.70 M | 14.84 M | 16.74 M | 17.34 M |
| Operating Income | -24.38 M | -14.47 M | -14.00 M | -15.15 M | -17.06 M | -17.34 M |
| Pretax Income | -23.69 M | -13.55 M | -12.88 M | -13.88 M | -15.68 M | -15.76 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -23.69 M | -13.55 M | -12.88 M | -13.88 M | -15.68 M | -15.76 M |
| EPS (Basic) | -1.06 | -0.60 | -0.58 | -0.62 | -0.70 | -0.71 |
| EPS (Diluted) | -1.06 | -0.60 | -0.58 | -0.62 | -0.70 | -0.71 |
| Shares Outstanding | 22.45 M | 22.41 M | 22.36 M | 22.39 M | 22.36 M | 22.30 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.